Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions

被引：8

作者：

Woo, Sook-Bin

Solomon, Daniel H.

机构：

[1] Brigham & Womens Hosp, Div Oral & Maxillofacial Surg Oral Med & Dent, Boston, MA 02120 USA

[2] Brigham & Womens Hosp, Div Rheumatol, Boston, MA USA

[3] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2007年 / 99卷 / 13期

关键词：

D O I：

10.1093/jnci/djm029

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：986 / 987

页数：2

共 15 条

[1] Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].

Badros, A ;

Weikel, D ;

Salama, A ;

Goloubeva, O ;

Schneider, A ;

Rapoport, A ;

Fenton, R ;

Gahres, N ;

Sausville, E ;

Ord, R ;

Meiller, T .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952

[2] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].

Bamias, A ;

Kastritis, E ;

Bamia, C ;

Moulopoulos, LA ;

Melakopoulos, L ;

Bozas, G ;

Koutsoukou, V ;

Gika, D ;

Anagnostopoulos, A ;

Papadimitriou, C ;

Terpos, E ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587

[3]

Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO

[4]

2-0

[5]

Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968

[6]

Durie BGM, 2005, NEW ENGL J MED, V353, P99

[7] Mayo Clinic consensus statement for the use of bisphosphonates in multiple myeloma [J].

Lacy, Martha Q. ;

Dispenzieri, Angela ;

Gertz, Morie A. ;

Greipp, Philip R. ;

Gollbach, Kimberly L. ;

Hayman, Suzanne R. ;

Kumar, Shaji ;

Lust, John A. ;

Rajkumar, S. Vincent ;

Russell, Stephen J. ;

Witzig, Thomas E. ;

Zeldenrust, Steven R. ;

Dingli, David ;

Bergsagel, P. Lief ;

Fonseca, Rafael ;

Reeder, Craig B. ;

Stewart, A. Keith ;

Roy, Vivek ;

Dalton, Robert J. ;

Carr, Alan B. ;

Kademani, Deepak ;

Keller, Eugene E. ;

Vilozzi, Christopher V. ;

Kyle, Robert A. .

MAYO CLINIC PROCEEDINGS, 2006, 81 (08) :1047-1053

[8]

Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO

[9]

2-Z

[10] Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic [J].

Marx, RE .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (09) :1115-1117

← 1 2 →